PMID- 36528565
OWN - NLM
STAT- MEDLINE
DCOM- 20221220
LR  - 20230817
IS  - 1471-2474 (Electronic)
IS  - 1471-2474 (Linking)
VI  - 23
IP  - 1
DP  - 2022 Dec 17
TI  - Combined arthroscopic release with corticosteroid hydrodilatation versus 
      corticosteroid hydrodilatation only in treating freezing-phase primary frozen 
      shoulder: a randomized clinical trial.
PG  - 1102
LID - 10.1186/s12891-022-06065-3 [doi]
LID - 1102
AB  - BACKGROUND: There has been no ideal treatment for freezing-phase frozen shoulder 
      to rapidly relieve pain and improve joint mobility. No any other team directly 
      compared the effectiveness of combination of arthroscopic release and 
      corticosteroid hydrodilatation with corticosteroid hydrodilatation only in 
      treatment of freezing-phase frozen shoulder. METHODS: Seventy-two patients with 
      freezing-phase frozen shoulder were randomly assigned to combined arthroscopic 
      release with corticosteroid hydrodilatation (group A) or corticosteroid 
      hydrodilatation only (group B). Clinical states were examined at baseline and 
      periodically (Weeks 1, 4, 12, 24 and 1 year) after intervention by passive ROM; 
      visual analog scale (VAS); UCLA and Disabilities of the Arm, Shoulder, and Hand 
      (DASH) score. RESULTS: The passive ROM, VAS, UCLA and DASH scores always improved 
      along the time points (all p < 0.01). The passive abduction (pAB), passive 
      forward flexion (pFL), passive external rotation (pER), passive internal rotation 
      (pIR) were better in group A than in group B at Week 1, 4, 12, 24 (all p < 0.01). 
      At 1 year post-operation, the pFL and pIR were better in group A than in group B 
      (all p < 0.01). VAS scores of group A were similar with those of group B (all 
      p > 0.01), the differences between group A and group B were all lower than 
      minimal clinically important difference (MCID). At Week 12, the UCLA sores and 
      DASH scores were 26.8 +/- 3.8, 14.2 +/- 2.0 in group A versus 22.3 +/- 3.4, 22.5 +/- 3.1 
      in group B (all p < 0.01). At Week 24 post-operation, there were 32.7 +/- 2.0, 
      9.8 +/- 1.5 in group A versus 26.3 +/- 3.6, 17.5 +/- 3.5 in group B (all p < 0.01). At 
      1 year post-operation, there were 34.5 +/- 0.8, 1.7 +/- 1.5 in group A versus 
      32.1 +/- 2.3, 8.8 +/- 2.8 in group B (all p < 0.01), the differences of UCLA scores 
      between group A and group B at Week 24 was higher than the MCID. There were no 
      complications such as infection, nerve or vascular injury. CONCLUSIONS: Combined 
      arthroscopic release with corticosteroid hydrodilatation would yield better 
      results in passive ROM and function than corticosteroid hydrodilatation only. 
      TRIAL REGISTRATION: ChiCTR1900024235, July 2, 2019 (Retrospectively registered).
CI  - (c) 2022. The Author(s).
FAU - Dai, Zhu
AU  - Dai Z
AUID- ORCID: 0000-0003-1512-2775
AD  - Department of Orthopaedics, the First Affiliated Hospital, Hengyang Medical 
      School, University of South China, Hengyang, 421001, Hunan, China. 
      oliverdai@hotmail.com.
FAU - Liu, Quanhui
AU  - Liu Q
AD  - Department of Orthopaedics, the First Affiliated Hospital, Hengyang Medical 
      School, University of South China, Hengyang, 421001, Hunan, China.
FAU - Liu, Bo
AU  - Liu B
AD  - Department of Orthopaedics, the First Affiliated Hospital, Hengyang Medical 
      School, University of South China, Hengyang, 421001, Hunan, China.
FAU - Long, Ke
AU  - Long K
AD  - Department of Orthopaedics, the First Affiliated Hospital, Hengyang Medical 
      School, University of South China, Hengyang, 421001, Hunan, China.
FAU - Liao, Ying
AU  - Liao Y
AD  - Department of Orthopaedics, the First Affiliated Hospital, Hengyang Medical 
      School, University of South China, Hengyang, 421001, Hunan, China.
FAU - Wu, Biao
AU  - Wu B
AD  - Department of Orthopaedics, the First Affiliated Hospital, Hengyang Medical 
      School, University of South China, Hengyang, 421001, Hunan, China.
FAU - Huang, Wen
AU  - Huang W
AD  - Department of Orthopaedics, the First Affiliated Hospital, Hengyang Medical 
      School, University of South China, Hengyang, 421001, Hunan, China.
FAU - Liu, Chao
AU  - Liu C
AD  - Department of Orthopaedics, the First Affiliated Hospital, Hengyang Medical 
      School, University of South China, Hengyang, 421001, Hunan, China.
LA  - eng
GR  - 20201907/Health Commission of Hunan Province/
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20221217
PL  - England
TA  - BMC Musculoskelet Disord
JT  - BMC musculoskeletal disorders
JID - 100968565
RN  - 0 (Adrenal Cortex Hormones)
SB  - IM
CIN - J Bone Joint Surg Am. 2023 Aug 16;105(16):1281. PMID: 37315122
MH  - Humans
MH  - *Shoulder Joint/surgery
MH  - Freezing
MH  - *Bursitis/drug therapy/surgery
MH  - Range of Motion, Articular/physiology
MH  - Adrenal Cortex Hormones/therapeutic use
MH  - Pain
MH  - Treatment Outcome
PMC - PMC9758809
OTO - NOTNLM
OT  - Arthroscopic release
OT  - Corticosteroid injection
OT  - Frozen shoulder
OT  - Hydrodilatation
COIS- There were no potential conflicts of interest of all authors.
EDAT- 2022/12/18 06:00
MHDA- 2022/12/21 06:00
PMCR- 2022/12/17
CRDT- 2022/12/17 23:13
PHST- 2022/05/07 00:00 [received]
PHST- 2022/12/06 00:00 [accepted]
PHST- 2022/12/17 23:13 [entrez]
PHST- 2022/12/18 06:00 [pubmed]
PHST- 2022/12/21 06:00 [medline]
PHST- 2022/12/17 00:00 [pmc-release]
AID - 10.1186/s12891-022-06065-3 [pii]
AID - 6065 [pii]
AID - 10.1186/s12891-022-06065-3 [doi]
PST - epublish
SO  - BMC Musculoskelet Disord. 2022 Dec 17;23(1):1102. doi: 
      10.1186/s12891-022-06065-3.